Trial intelligence / Profile preview

Ketorolac Add-on to Prochlorperazine for Pediatric Migraine

NCT01534806Phase 4Withdrawn

Sponsor
Akron Children's Hospital
Start
Jan 2012
Primary completion
Jan 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of ketorolac in migraine, sponsored by Akron Children's Hospital. Planned start Jan 2012; status: withdrawn.

02

Drugs

ketorolac
03

Conditions

migraine

Beyond the preview

Go deeper on NCT01534806.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01534806.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call